Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Seib Premiums topic
No spam. Unsubscribe anytime.
SEIB official tells committee a $30.5 million trust‑fund draw was used to shore up benefits
Summary
Miss Azar told legislators the State Employee Insurance Board approved a $30.5 million withdrawal from the retiree trust to cover 2026 shortfalls and warned that holding this year’s 11.75 state rate could require another trust draw in 2026.
Get email alerts on the Seib Premiums topic
No spam. Unsubscribe anytime.
Miss Azar, a SEIB representative, told the Joint Interim Committees that the State Employee Insurance Board had approved a $30,500,000 transfer from the retiree trust to the SEIB account to cover shortfalls projected for 2026.
The move, Azar said, followed years of federal subsidy shifts and rising health‑care inflation. "The board in September, this is very important because of the financial situation of SEIB is agreed and voted to approve a pool from the trust fund, retiree trust fund for $30,500,000," she said, adding that the board also approved benefit changes projected to save roughly $2.7 million in 2026 and more in 2027.
Why it matters: SEIB funds premiums for state employees and retirees; Azar said about 30% of the employer share in the state rate is covered by the general fund while the remainder is drawn from other agencies, federal dollars and fees. She told lawmakers the proposed state rate before the committee was designed to close a funding gap conservatively, but still leaves the program vulnerable: "If you give us November today and then you next year you just keep it November, we're in the red," she said.
Supporting details: Azar and SEIB actuaries showed multi‑year trend charts the committee requested, noting an average annual medical increase of 3.9% over 2016–2024 and prescription‑drug increases averaging 11.3% over the same period. The presentation incorporated actuarial assumptions: for the state‑rate package Azar said SEIB included a 5.7% medical and 10% drug assumption.
Committee response and next steps: Committee members pressed for the underlying slide deck and for granular year‑over‑year cost breakdowns to see which segments of the health dollar rose most. Azar offered to meet individually and to supply the actuarial backup. Lawmakers flagged the plan’s reliance on one‑time trust funds and asked SEIB staff to return with options to avoid repeating trust draws.
The hearing record shows no vote or formal action by the committee on the rate during this session; staff said the materials would be circulated for separate study.

